VERU Veru Inc
Company Analysis
Latest News
🟢 Veru is trading 5% up today as XBI gains 2.06%
Veru is trading 5.02% up at $2.72, with biotech-sector momentum the strongest available explanation; no new company-specific announcement was identified on...
🔴 Veru is trading 5.9% down in pre-market with no new catalyst identified
Veru is trading 5.9% down now at $2.54 (-5.93%), with no new company-specific catalyst identified for August 14, 2026. • Veru’s latest major announcement was...
🔴 Veru is trading 5.65% down in pre-market
Veru is trading 5.65% down now at $2.61, with no confirmed catalyst identified for the August 11 pre-market decline. - Veru gained 18.88% to $2.77 on August...
🔴 Veru is trading 5% down in after-hours trading after Q3 loss and effectively zero revenue
Veru is trading 5.05% down at $2.63 after fiscal third-quarter results showed a $0.30-per-share loss and effectively zero revenue. - The loss modestly beat...
Veru Beats Q3 Estimates and Overfills Its Obesity Trial — But Can a $36 Million Biotech Survive Long Enough to Prove Its Drug Works?
Shares of Veru Inc. surged 15% to $2.68 Monday morning after the company posted fiscal third-quarter results that narrowed losses faster than Wall Street...
🟢 Veru is trading 15% up today after narrower-than-expected Q3 EPS loss
Veru is trading 15.02% up now at $2.68 after fiscal Q3 2026 results showed a narrower-than-expected $0.30 EPS loss and continued progress in its obesity...
Veru Inc's third quarter 2026 EPS loss of $0.30 beat estimates as enobosarm trial enrollment exceeded targets
Veru reported a narrower-than-anticipated net loss for its third quarter of fiscal 2026, although revenue was effectively non-existent as the company continues...
Veru Inc Q3 2026 Earnings Preview: What Analysts Expect on August 10, 2026
Veru is expected to report a consensus revenue of $3.15 million and an EPS loss of -$0.34 for the fiscal quarter ending June 30, 2026, while the current stock...
🟢 Veru is trading 5.1% up today, extending gains on Novo Nordisk obesity trial supply deal
Veru is trading 5.1% up today at $2.38, continuing a multi-day rebound following its clinical supply agreement with Novo Nordisk for the PLATEAU Phase 2b...
🟢 Veru is trading 5.1% up today after exceeding enrollment for Phase 2b obesity trial
Veru is trading 5.1% up at $2.37 after announcing it has completed and exceeded enrollment for its Phase 2b PLATEAU trial of oral enobosarm plus semaglutide in...
Veru Completes Enrollment for Phase 2b Weight-Loss Drug Trial
Veru Inc. completed and exceeded its targeted enrollment of 200 patients for the Phase 2b PLATEAU clinical trial. The study evaluates oral enobosarm combined...
🟢 Veru is trading 5.8% up today amid a modest risk-on tone in U.S. futures
Veru is trading 5.78% up at $2.38 in pre-market action, though no company-specific catalysts have been identified to explain the move. • The price action...
🔴 Veru is trading 5.2% down today amid broad biotech and market weakness
Veru is trading 5.2% down at $2.29, giving back part of yesterday’s bounce as the stock tracks a broader market decline. • There are no fresh company-specific...
🔴 Veru is trading 5.1% down today on continued post-rally profit-taking
Veru is trading 5.1% down at $2.43 as investors continue to lock in gains following its recent Novo Nordisk clinical supply deal and strong Q2 fiscal 2026...
🔴 Veru is trading 5% down today on profit-taking after Novo Nordisk-driven rally
Veru is trading approximately 5% down today at $2.64 as the stock undergoes a period of consolidation following a recent rally fueled by a Novo Nordisk...
🔴 Veru is trading 5.2% down today on profit-taking after recent Novo Nordisk-driven rally
Veru is trading 5.2% down at $2.67 today as the stock undergoes profit-taking and consolidation following its recent sharp rally. • The previous multi-day...
🟢 VERU is trading 5.5% up today, rebounding from a prior-session drop and after-hours momentum
VERU is trading 5.5% up at $2.81 as it rebounds from yesterday's decline and continues its after-hours momentum. • The stock is recovering from a 7.6% drop in...
🟢 Veru Inc is trading 7.95% up in after-hours
VERU is trading at $2.87, up 7.95% in after-hours.
🔴 VERU extends move to 5.2% down
VERU is trading at $2.73, down 5.2% versus the comparison close of $2.88 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 VERU is trading 6.25% down today amid continued volatility
VERU is trading at $2.70 (-6.25%) following a sharp early-session drop, which appears to be a continuation of recent volatility. • No major company-specific...